Search results
Results from the WOW.Com Content Network
(Reuters) - The U.S. Centers for Disease Control and Prevention said on Thursday it has expedited the release of more than 77,000 additional doses of Sanofi and AstraZeneca's respiratory syncytial ...
The Centers for Disease Control and Prevention (CDC) said it was releasing 77,000 additional doses of a respiratory syncytial virus (RSV) drug from Sanofi and AstraZeneca to help improve its ...
Infants should get a recently approved drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, U.S. health officials said ...
The CDC began supplying doses to the SNS in 2007 under a now $427 million contract with the DHHS, according to a Cangene press release. In 2010, the CDC replaced the licensed bivalent botulinum antitoxin AB (BAT-AB) and the investigational monovalent botulinum antitoxin E (BAT-E) with BAT when the former two products indications expired. This ...
The CDC approved Pfizer/BioNTech's (PFE/BNTX) bivalent COVID-19 booster for children ages 5-11 and Moderna's bivalent booster for ages 6-17 Wednesday, expanding access to protection against ...
The CDC will publish additional details on that research Thursday. COVID hospitalizations peaked at the beginning of January, with 35,000 hospitalizations a week. By Feb. 7, COVID hospitalizations ...
After the U.S. Food and Drug Administration (FDA) approved the emergency use of the 2024-2025 COVID-19 vaccines many questions are beginning to circulate.. In the FDA's press release on Aug. 22 ...
The Centers for Disease Control and Prevention must sign off and an advisory panel is set to issue recommendations Tuesday The post New COVID vaccines approved. CDC guidance on who should get it ...